146 related articles for article (PubMed ID: 33316539)
21. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.
Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA
Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675
[TBL] [Abstract][Full Text] [Related]
22. Immunocytochemical study of epidermal growth factor receptor, transforming growth factor alpha, and "squamous differentiation" in human endometrial carcinoma.
Santini D; Ceccarelli C; Martinelli GN; Leone O; Marabini A; Orlandi C; Mancini AM
Hum Pathol; 1994 Dec; 25(12):1319-23. PubMed ID: 7528164
[TBL] [Abstract][Full Text] [Related]
23. CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.
Uehara K; Ikehara F; Tanabe Y; Nakazato I; Oshiro M; Inamine M; Kinjo T
Diagn Pathol; 2016 Feb; 11():16. PubMed ID: 26830028
[TBL] [Abstract][Full Text] [Related]
24. The origin of p40-negative and CDX2-positive primary squamous cell carcinoma of the stomach: case report.
Yamagata Y; Saito K; Ban S; Fujii A; Oya M
World J Surg Oncol; 2019 Mar; 17(1):53. PubMed ID: 30890174
[TBL] [Abstract][Full Text] [Related]
25. How to approach the many faces of endometrioid carcinoma.
Malpica A
Mod Pathol; 2016 Jan; 29 Suppl 1():S29-44. PubMed ID: 26715172
[TBL] [Abstract][Full Text] [Related]
26. Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers.
Niu S; Lucas E; Molberg K; Strickland A; Wang Y; Carrick K; Rivera-Colon G; Gwin K; SoRelle JA; Castrillon DH; Zheng W; Chen H
Am J Surg Pathol; 2022 Oct; 46(10):1447-1455. PubMed ID: 35834400
[TBL] [Abstract][Full Text] [Related]
27. Endometrial serous carcinoma with extensive squamous differentiation mimicking primary endometrial squamous cell carcinoma: Clinicopathological and molecular analysis of a case with literature review.
Santoro A; Travaglino A; Arciuolo D; Fulgione C; Pasquini S; Minucci A; Raffone A; Inzani F; Zannoni GF
Pathol Res Pract; 2022 Dec; 240():154209. PubMed ID: 36423403
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.
Hoang LN; Lee YS; Karnezis AN; Tessier-Cloutier B; Almandani N; Coatham M; Gilks CB; Soslow RA; Stewart CJ; Köbel M; Lee CH
Histopathology; 2016 Oct; 69(4):560-9. PubMed ID: 27101785
[TBL] [Abstract][Full Text] [Related]
29. Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.
Miyamoto M; Takano M; Aoyama T; Soyama H; Yoshikawa T; Tsuda H; Furuya K
J Gynecol Oncol; 2018 Mar; 29(2):e20. PubMed ID: 29400013
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
31. Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients.
Stefansson IM; Salvesen HB; Akslen LA
Int J Cancer; 2006 Mar; 118(5):1227-33. PubMed ID: 16152605
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2 expression and prognosis of patients with endometrial carcinoma.
Sakuragi N; Ohkouchi T; Hareyama H; Ikeda K; Watari H; Fujimoto T; Kuwabara M; Yamamoto R; Sagawa T; Fujino T; Fujimoto S
Int J Cancer; 1998 Apr; 79(2):153-8. PubMed ID: 9583730
[TBL] [Abstract][Full Text] [Related]
33. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
34. Cellular organization and histogenesis of adenosquamous carcinoma of the pancreas: evidence supporting the squamous metaplasia concept.
Boecker W; Tiemann K; Boecker J; Toma M; Muders MH; Löning T; Buchwalow I; Oldhafer KJ; Neumann U; Feyerabend B; Fehr A; Stenman G
Histochem Cell Biol; 2020 Jul; 154(1):97-105. PubMed ID: 32170368
[TBL] [Abstract][Full Text] [Related]
35. Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review.
Liang SX; Patel K; Pearl M; Liu J; Zheng W; Tornos C
Int J Gynecol Pathol; 2007 Jul; 26(3):291-7. PubMed ID: 17581414
[TBL] [Abstract][Full Text] [Related]
36. Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases.
Němejcová K; Cibula D; Dundr P
Diagn Pathol; 2015 Mar; 10():8. PubMed ID: 25884453
[TBL] [Abstract][Full Text] [Related]
37. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.
Halperin R; Zehavi S; Habler L; Hadas E; Bukovsky I; Schneider D
Eur J Gynaecol Oncol; 2001; 22(2):122-6. PubMed ID: 11446475
[TBL] [Abstract][Full Text] [Related]
38. IFITM1 Is Superior to CD10 as a Marker of Endometrial Stroma in the Evaluation of Myometrial Invasion by Endometrioid Adenocarcinoma.
Busca A; Djordjevic B; Giassi A; Parra-Herran C
Am J Clin Pathol; 2016 Apr; 145(4):486-96. PubMed ID: 27124937
[TBL] [Abstract][Full Text] [Related]
39. Papillary syncytial metaplasia associated with endometrial breakdown exhibits an immunophenotype that overlaps with uterine serous carcinoma.
McCluggage WG; McBride HA
Int J Gynecol Pathol; 2012 May; 31(3):206-10. PubMed ID: 22498936
[TBL] [Abstract][Full Text] [Related]
40. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]